Trial intelligence / Profile preview

Thalidomide and Megestrol Acetate in Advanced Malignant Tumors

NCT03777930Phase 4Unknown

Sponsor
Luohu District People's Hospital
Start
Dec 2018
Primary completion
Oct 2020
Modality
Small Molecules
01

Overview

A Phase 4 trial of thalidomide, megestrol in cancer, sponsored by Luohu District People's Hospital. Status: unknown.

02

Drugs

thalidomidemegestrol
03

Conditions

cancer

Beyond the preview

Go deeper on NCT03777930.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03777930.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call